Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Vodafone Group Plc American Depositary Shares (VOD) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade
Vodafone Group Plc American Depositary SharesTrade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs Vodafone Group Plc American Depositary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Vodafone Group Plc American Depositary Shares trades at $15.56 (market cap $38.08B). The key difference: Vodafone Group Plc American Depositary Shares is far larger — about 3× Halozyme Therapeutics Inc. Common Stock's market cap, and Vodafone Group Plc American Depositary Shares pays a 3.26% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Vodafone Group Plc American Depositary Shares for 0 Days on average.

HALOVOD
Market Cap
$12.58B$38.08B
Volume
2,179,2783,820,235
Sector
HealthMedia
52-Week High
$115.22$17.68
52-Week Low
$61.63$11.17
Typical Hold Time
1 Days0 Days
Enterprise Value
$14.49B$83.23B
Dividend Yield
—3.26%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HALO

No sentiment data available yet.

VOD
100% Buy0% Sell
Avg holding period · 0 Days

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About Vodafone Group Plc American Depositary Shares

Vodafone provides mobile, fixed-line, broadband, and business communications services. It operates across Europe and Africa.

Read more on VOD →